If the population-based ER-negative PRSs were also associated primarily with ER-negative breast cancers in BRCA1 mutation carriers, the ER-negative PRS would be more predictive of breast cancer in BRCA1 carriers at younger ages. The gene discussed is BRCA1; the disease is breast carcinoma.